Free alerts

CADL insider buying

Every open-market purchase of Candel Therapeutics, Inc. (CADL) stock by its officers, directors and major shareholders, from SEC Form 4 filings.

Bought, last 12 months$3M
Insiders buying (12m)1
Purchases on record1
Last purchase filedFeb 26, 2026

In the last 12 months, 1 insider of Candel Therapeutics, Inc. bought $3M of CADL stock on the open market in 1 reported purchase. The most recent was filed on Feb 26, 2026: Manning Paul B (Director) bought 550,458 shares at $5.45, worth $3M.

Get the next CADL insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All CADL insider purchases

FiledInsiderValueSharesPriceStakeTrade
Feb 26Manning Paul BDirector$3M550,458$5.45+25%Feb 23SEC